PLoS ONE · 2014 · 14 citations · 31 references
Life SciencesImmunologyInfectious DiseasesGene ExpressionInnate ImmunityMolecular VirologyAntiviral ImmunityInnate Immune ActivationInnate Immune ResponseInnate Immune Signaling PathwaysInterferon ResponsesViral HepatitisAntiviral Innate Immune SignalingAntiviral Innate SignalingAntiviral Interferon ResponsesHost Antiviral ResponseInnate Immune Signaling GenesInterferon ProductionInterferon Response To Viral InfectionType I Interferon Responses
Several viruses are known to infect human liver and cause the hepatitis, but the interferon (IFN) response, a first-line defense against viral infection, of virus-infected hepatocytes is not clearly defined yet. We investigated innate immune system against RNA viral infection in immortalized human hepatocytes (HuS-E/2 cells), as the cells showed similar early innate immune responses to primary human hepatocytes (PHH). The low-level constitutive expression of IFN-α1 gene, but not IFN-β and IFN-λ, was observed in both PHH and HuS-E/2 cells in the absence of viral infection, suggesting a particular subtype(s) of IFN-α is constitutively produced in human hepatocytes. To examine the functional role of such IFN-α in the antiviral response, the expression profiles of innate immune-related genes were studied in the cells with the treatment of neutralization against type I IFN receptor 2 (IFNAR2) or IFN-α itself to inhibit the constitutive IFN-α signaling before and after virus infection. As the results, a clear reduction of basal level expression of IFN-inducible genes was observed in uninfected cells. When the effect of the inhibition on the cells infected with hepatitis C virus (HCV) was examined, the significant decrease of IFN stimulated gene expression and the enhancement of initial HCV replication were observed, suggesting that the steady-state production of IFN-α plays a role in amplification of antiviral responses to control the spread of RNA viral infection in human hepatocytes.
31
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Hiroki Kato, Osamu Takeuchi, Shintaro Sato et al. · Nature · 2006 · 3.8K citations
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Etienne Meylan, Joseph Curran, Kay Hofmann et al. · Nature · 2005 · 2.4K citations · Full text
Cell Type-Specific Involvement of RIG-I in Antiviral Response
Hiroki Kato, Shintaro Sato, Mitsutoshi Yoneyama et al. · Immunity · 2005 · 1.3K citations · Full text